Researcher profile

Marianne S. Muhlebach

Marianne S. Muhlebach contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 11 - UnverifiedVerification L1Unclaimed author
1works
0followers
2topics
3close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

1 published item(s)

preprint2022arXiv

Risk-Adjusted Incidence Modeling on Hierarchical Survival Data with Recurrent Events

There is a constant need for many healthcare programs to timely address problems with infection prevention and control (IP&C). For example, pathogens can be transmitted among patients with cystic fibrosis (CF) in both the inpatient and outpatient settings within the healthcare system even with the existing recommended IP&C practices, and these pathogens are often associated with negative clinical outcomes. Because of limited and delayed data sharing, CF programs need a reliable method to track infection rates. There are three complex structures in CF registry data: recurrent infections, missing data, and multilevel correlation due to repeated measures within a patient and patient-to-patient transmissions. A step-by-step analysis pipeline was proposed to develop and validate a risk-adjusted model to help healthcare programs monitor the number of recurrent events while taking into account missing data and the hierarchies of repeated measures in right-censored data. We extended the mixed-effect Andersen-Gill model (the frailty model), adjusted for important risk factors, and provided confidence intervals for the predicted number of events where the variability of the prediction was estimated from three identified sources. The coverage of the estimated confidence intervals was used to evaluate model performance. Simulation results indicated that the coverage of our method was close to the desired confidence level. To demonstrate its clinical practicality, our pipeline was applied to monitor the infection incidence rate of two key CF pathogens using a U.S. registry. Results showed that years closer to the time of interest were better at predicting future incidence rates in the CF example.